Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PANTOPRAZOLE Cause Hepatocellular injury? 340 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 340 reports of Hepatocellular injury have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 0.4% of all adverse event reports for PANTOPRAZOLE.

340
Reports of Hepatocellular injury with PANTOPRAZOLE
0.4%
of all PANTOPRAZOLE reports
10
Deaths
229
Hospitalizations

How Dangerous Is Hepatocellular injury From PANTOPRAZOLE?

Of the 340 reports, 10 (2.9%) resulted in death, 229 (67.4%) required hospitalization, and 29 (8.5%) were considered life-threatening.

Is Hepatocellular injury Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 340 reports have been filed with the FAERS database.

What Other Side Effects Does PANTOPRAZOLE Cause?

Chronic kidney disease (28,127) Acute kidney injury (15,961) Renal failure (11,543) End stage renal disease (8,523) Renal injury (7,070) Drug ineffective (5,487) Off label use (4,279) Pain (4,057) Dyspnoea (4,052) Fatigue (3,797)

What Other Drugs Cause Hepatocellular injury?

ACETAMINOPHEN (1,761) METHOTREXATE (683) ATORVASTATIN (610) SULFAMETHOXAZOLE\TRIMETHOPRIM (415) ENOXAPARIN (365) TRAMADOL (349) AMOXICILLIN (347) ESOMEPRAZOLE (341) VINCRISTINE (306) METHYLPREDNISOLONE (300)

Which PANTOPRAZOLE Alternatives Have Lower Hepatocellular injury Risk?

PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS PANTOPRAZOLE vs PANTOTHENIC ACID PANTOPRAZOLE vs PAPAVERINE PANTOPRAZOLE vs PARACETAMOL PANTOPRAZOLE vs PARATHYROID HORMONE

Related Pages

PANTOPRAZOLE Full Profile All Hepatocellular injury Reports All Drugs Causing Hepatocellular injury PANTOPRAZOLE Demographics